United Therapeutics
UTHR
United Therapeutics (UTHR) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| RBC Capital | Maintained | Outperform | $677.00 from $704.00 | Aug 6, 2026 |
| JP Morgan | Maintained | Overweight | $687.00 from $685.00 | Jul 23, 2026 |
| B of A Securities | Maintained | Neutral | $613.00 from $620.00 | Jul 10, 2026 |
| RBC Capital | Maintained | Outperform | $704.00 from $701.00 | Jul 7, 2026 |
| Wells Fargo | Upgraded | Equal-Weight → Overweight | $738.00 from $575.00 | May 7, 2026 |
| RBC Capital | Maintained | Outperform | $701.00 from $707.00 | May 7, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $519.00 from $471.00 | Apr 10, 2026 |
| B of A Securities | Maintained | Neutral | $626.00 from $569.00 | Mar 31, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $575.00 from $486.00 | Mar 31, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $660.00 from $600.00 | Mar 31, 2026 |
| TD Cowen | Maintained | Buy | $660.00 from $575.00 | Mar 30, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $486.00 from $466.00 | Mar 23, 2026 |
| Cantor Fitzgerald | Maintained | Overweight | $625.00 from $525.00 | Mar 12, 2026 |
| UBS | Maintained | Buy | $705.00 from $655.00 | Mar 5, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $466.00 from $423.00 | Feb 26, 2026 |
| RBC Capital | Maintained | Outperform | $643.00 from $587.00 | Feb 26, 2026 |
| Oppenheimer | Maintained | Outperform | $600.00 from $575.00 | Feb 26, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $600.00 from $525.00 | Feb 26, 2026 |
| TD Cowen | Maintained | Buy | $575.00 from $525.00 | Feb 26, 2026 |
| UBS | Maintained | Buy | $645.00 from $600.00 | Jan 6, 2026 |
Frequently asked questions
What is the latest analyst rating on UTHR?
On Aug 6, 2026, RBC Capital maintained United Therapeutics at Outperform with a price target of $677.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.